ANGPTL3: a therapeutic target for atherosclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://www.nature.com/articles/nrcardio.2017.91.pdf
Reference2 articles.
1. Dewey, F. E. et al. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1612790 (2017)
2. Graham, M. J. et al. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1701329 (2017)
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging;Pharmaceutics;2024-08-03
2. Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery;Biomaterials;2024-07
3. Zebrafish ApoB-Containing Lipoprotein Metabolism: A Closer Look;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-05
4. Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease;Cardiovascular Research;2024-05
5. Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies;Annals of Medicine & Surgery;2024-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3